Tuesday, December 16, 2014

Webcast Tomorrow

It has been an interesting year for those of us with a fibrotic lung disease. The FDAs approval of two drugs to treat IPF is a first. There was no treatment for people with IPF, other than transplants. The drugs have shown to reduce the steady and fast march of the disease by thirty-percent. Hopefully, insurance companies will soon allow these drugs to be used off label, for those of us with other ILDs.

There is a free webcast tomorrow. Follow the information below.


email header
 
The last few weeks have been such an exciting time for the idiopathic pulmonary fibrosis community. To inform you about a treatment option and the patient support program associated with it, we are sharing an important learning opportunity with you.
You are invited to attend a free webcast on December 17, 2014 at 1:00 PM ET in which a representative from Boehringer Ingelheim will introduce you to their IPF patient support program -- a series of free services, such as a 24-hour nursing hotline, locations of local support groups and financial assistance, which are provided by Boehringer Ingelheim.
There is too much information on Boehringer Ingelheim’s patient support program to include in this invitation, so please join us on December 17, 2014 at 1:00 PM ET to learn more!
Here are the details:
Date: December 17, 2014
Time: 1:00 PM ET
Dial-in: 1-877-870-4263

Sincerely,
The Coalition for Pulmonary Fibrosis
 
 
 
Coalition for Pulmonary Fibrosis
10866 W. Washington Blvd. #343
Culver City, CA 90232
(888) 222-8541
info@coalitionforpf.org
 

No comments: